Gut podcast show

Gut podcast

Summary: From June 2023, all our podcasts will move to https://gutbmj.podbean.com. You can continue with your subscription on your favourite podcast App. Gut is a leading international journal in gastroenterology and hepatology. It has an established reputation for publishing first class clinical research of the alimentary tract, the liver, biliary tree and pancreas. Gut delivers up-to-date, authoritative, clinically oriented coverage of all areas in gastroenterology. Regular features include articles by leading authorities, reports on the latest treatments for diseases, reviews and commentaries. Subscribers to Gut also receive Frontline Gastroenterology (FG). The Gut Podcast discusses highlights from its issues monthly. Please subscribe in all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify. * The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.

Podcasts:

 Dysosmobacter welbionis, a new human commensal bacterium preventing diet-induced obesity | File Type: audio/mpeg | Duration: 11:39

Dr Philip Smith, Digital and Education Editor of Gut and Consultant Gastroenterologist at the Royal Liverpool Hospital interviews Professor Patrice Cani, Louvain Drug Research Institute, WELBIO, Metabolism and Nutrition, UCLouvain, Brussels, Belgium and Emilie Moens de Hase a PhD student in the same institution. This Gut podcast is focused on the paper "Dysosmobacter welbionis is a newly isolated human commensal bacterium preventing diet-induced obesity and metabolic disorders in mice" which is published in paper copy in Gut in March 2022, and is available here: https://gut.bmj.com/content/71/3/534 Please subscribe to the Gut Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month. If you enjoy our podcast, please consider leaving us a review or a comment on the Gut Podcast iTunes page (https://podcasts.apple.com/gb/podcast/gut-podcast/id330976727).

 Gut microbiota modulates COPD pathogenesis: role of anti-inflammatory Pg-LPS | File Type: audio/mpeg | Duration: 11:36

Dr Philip Smith, Digital and Education Editor of Gut and Consultant Gastroenterologist at the Royal Liverpool Hospital, interviews Dr Lu from the Department of Respiratory Care, College of Medicine, Fu Jen Catholic University, Taiwan, and Drs Lai and Dr Lin from the Department of Medical Biotechnology and Laboratory Science, and Microbiota Research Center, College of Medicine, Chang Gung University, Taiwan. The Gut podcast is focused on the paper "Gut microbiota modulates COPD pathogenesis: role of anti-inflammatory Parabacteroides goldsteinii lipopolysaccharide", which is published in paper copy in Gut in February 2022, and is available here: https://gut.bmj.com/content/71/2/309 Please subscribe to the Gut Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month. If you enjoy our podcast, please consider leaving us a review or a comment on the Gut Podcast iTunes page (https://podcasts.apple.com/gb/podcast/gut-podcast/id330976727).

 Proton pump inhibitors and risk of colorectal cancer | File Type: audio/mpeg | Duration: 7:03

Dr Philip Smith, Digital and Education Editor of Gut and Consultant Gastroenterologist at the Royal Liverpool Hospital, interviews Dr Laurent Azoulay and Dr Devin Abrahami, from the Centre for Clinical Epidemiology, Lady Davis Institute for Medical Research, and McGill University, Montreal, Canada. Dr. Abrahami is now a postdoctoral fellow at the Brigham and Women’s Hospital and Harvard Medical School. This Gut podcast is focused on the paper "Proton pump inhibitors and risk of colorectal cancer", which is published in paper copy in Gut in January 2022, and is available here: https://gut.bmj.com/content/71/1/111. Please subscribe to the Gut Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month. If you enjoy our podcast, please consider leaving us a review or a comment on the Gut Podcast iTunes page (https://podcasts.apple.com/gb/podcast/gut-podcast/id330976727). Thank you for listening.

 Sugar-sweetened beverage intake and risk of early-onset colorectal cancer among women | File Type: audio/mpeg | Duration: 7:35

Dr Philip Smith, Digital and Education Editor of Gut and Consultant Gastroenterologist at the Royal Liverpool Hospital, interviews Professor Cao, Associate Professor of Surgery, Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri. This Gut podcast is focused on the paper "Sugar-sweetened beverage intake in adulthood and adolescence and risk of early-onset colorectal cancer among women", which is published in paper copy in Gut in December 2021, and is available here: https://gut.bmj.com/content/70/12/2330.

 Diet quality and risk and severity of COVID-19: a prospective cohort study | File Type: audio/mpeg | Duration: 7:26

Dr Philip Smith, Digital and Education Editor of Gut and Consultant Gastroenterologist at the Royal Liverpool Hospital, interviews Professor Andrew Chan, Harvard Medical School, Boston, USA. This podcast is focused on the paper "Diet quality and risk and severity of COVID-19: a prospective cohort study", published in paper copy in Gut in November 2021. Link to the paper: https://gut.bmj.com/content/70/11/2096

 Helicobacter pylori resistance to antibiotics in Europe | File Type: audio/mpeg | Duration: 6:32

Dr Philip Smith, Digital and Education Editor of Gut and Consultant Gastroenterologist at the Royal Liverpool Hospital, interviews Professor Megraud, University of Bordeaux, France. The podcast is focused on the paper "Helicobacter pylori resistance to antibiotics in Europe in 2018 and its relationship to antibiotic consumption in the community”, which is published in paper copy in Gut in October 2021. Link to the paper: https://gut.bmj.com/content/70/10/1815

 Blue poo: impact of gut transit time on the gut microbiome using a novel marker | File Type: audio/mpeg | Duration: 10:31

In this podcast, we'll explore how eating a ‘blue’ muffin is an inexpensive and scalable technique allowing the measurement of transit time. The method was used to assess the relationship between gut transit time and the human gut microbiome, in a study published in paper copy in Gut, in September 2021. "Blue poo: impact of gut transit time on the gut microbiome using a novel marker" is accessible here: https://gut.bmj.com/content/70/9/1665 Dr Philip Smith, Digital and Education Editor of Gut and Consultant Gastroenterologist at the Royal Liverpool Hospital, interviews Dr Sarah Berry, Department of Nutritional Sciences, King's College London, London. The Gut Podcast discusses highlights from its issues monthly. Please subscribe in all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify.

 Long-term dietary patterns associated with inflammatory features of the gut microbiome | File Type: audio/mpeg | Duration: 14:47

Dr Philip Smith, Digital and Education Editor of Gut and Consultant Gastroenterologist at the Royal Liverpool Hospital interviews Laura Bolte dietitian and PhD student from the Department of Gastroenterology and Hepatology and the Department of Genetics, University of Groningen and University Medical Centre Groningen, Groningen, The Netherlands and Professor Rinse Weersma from the Department of Gastroenterology and Hepatology at the University of Groningen and University Medical Centre Groningen, The Netherlands. The Gut podcast is focussed on the paper "Long-term dietary patterns are associated with pro-inflammatory and anti-inflammatory features of the gut microbiome" which is published in paper copy in Gut in July 2021. Related or relevant article: https://gut.bmj.com/content/70/7/1287

 Association between Brachyspira and irritable bowel syndrome with diarrhoea | File Type: audio/mpeg | Duration: 13:07

Dr Philip Smith, Digital and Education Editor of Gut and Consultant Gastroenterologist at the Royal Liverpool Hospital interviews Professor Gunnar C. Hansson from the Mucin Biology Groups, Department of Medical Biochemistry and Cell Biology, University of Gothenburg, Sweden. The Gut podcast is focussed on the paper "Association between Brachyspira and irritable bowel syndrome with diarrhoea" which is published in paper copy in Gut in June 2021. Related or relevant article: https://gut.bmj.com/content/70/6/1117

 Effect of IBD medications on COVID-19 outcomes | File Type: audio/mpeg | Duration: 13:33

Dr Philip Smith, Digital and Education Editor of Gut and Consultant Gastroenterologist at the Royal Liverpool Hospital interviews Dr Ryan Ungaro, who is an Assistant Professor at Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, USA. The podcast is focussed on ‘Effect of IBD medications on COVID-19 outcomes: results from an international registry’ published in paper copy in Gut in April 2021. Related or relevant article: https://gut.bmj.com/content/70/4/725

 CLARITY IBD: Anti-SARS-CoV-2 antibody and vaccination responses in patients treated with infliximab | File Type: audio/mpeg | Duration: 19:32

Dr Philip Smith, Digital and Education Editor of Gut and Consultant Gastroenterologist at the Royal Liverpool Hospital, interviews Dr Tariq Ahmad and Dr Nick Kennedy, both from the Department of Gastroenterology, Royal Devon and Exeter NHS Foundation Trust, UK. This special Gut podcast is focused on ‘Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab’ which is published in paper copy in Gut in May 2021 and the recently published paper ‘Infliximab is associated with attenuated immunogenicity to BNT162b2 and ChAdOx1 nCoV-19 SARS-CoV-2 vaccines’. Acknowledgements: The CLARITY IBD team would like to thank the CLARITY IBD team in Exeter, all of the 92 CLARITY IBD sites and over 7000 participants in the study. We are grateful to support from the NIHR CRN, Crohn's & Colitis UK and our funders. The related links: https://gut.bmj.com/content/early/2021/04/25/gutjnl-2021-324789 https://gut.bmj.com/content/70/5/865

 Long-term instability of the intestinal microbiome and its associations | File Type: audio/mpeg | Duration: 13:26

Dr Philip Smith, Digital and Education Editor of Gut and Consultant Gastroenterologist at the Royal Liverpool Hospital, interviews Dr Fabian Frost who is a clinical scientist, internal medicine specialist and gastroenterologist in training working at the Department of Medicine A, University Medicine Greifswald, Germany. The podcast is focussed on ‘Long-term instability of the intestinal microbiome is associated with metabolic liver disease, low microbiota diversity, diabetes mellitus and impaired exocrine pancreatic function’, published in paper copy in Gut, in March 2021. Link to the paper: https://gut.bmj.com/content/70/3/522.

 Neutrophils interact with cholangiocytes to cause cholestatic changes in alcoholic hepatitis | File Type: audio/mpeg | Duration: 11:17

Dr Philip Smith, Digital and Education Editor of Gut and Consultant Gastroenterologist at the Royal Liverpool Hospital, UK, interviews Professor Nathanson, the Gladys Phillips Crofoot Professor of Medicine and Cell Biology at Yale University and the Director of the Yale Liver Center, Yale University School of Medicine, New Haven, Connecticut, USA. The podcast is focussed on "Neutrophils interact with cholangiocytes to cause cholestatic changes in alcoholic hepatitis", published in paper copy in Gut, in February 2021. Read it on the Gut website: http://dx.doi.org/10.1136/gutjnl-2020-322540

 Screening and eradication of Helicobacter pylori for gastric cancer prevention | File Type: audio/mpeg | Duration: 12:43

Dr Philip Smith, Digital and Education Editor of Gut and Consultant Gastroenterologist at the Royal Liverpool Hospital, UK, interviews Professor Jyh-Ming Liou, Professor of Gastroenterology, Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan. The podcast is focussed on "Screening and eradication of Helicobacter pylori for gastric cancer prevention: the Taipei global consensus" published in paper copy in Gut in December 2020. Read the related article: https://gut.bmj.com/content/69/12/2093

 European Registry on Helicobacter pylori management (Hp-EuReg) | File Type: audio/mpeg | Duration: 7:01

Dr Philip Smith, Digital and Education Editor of Gut and Consultant Gastroenterologist at the Royal Liverpool Hospital, UK, interviews Professor Gisbert from the Gastroenterology Department, University Hospital of La Princesa, Madrid, Spain. The podcast is focused on "European Registry on Helicobacter pylori management (Hp-EuReg): patterns and trends in first-line empirical eradication prescription and outcomes of 5 years and 21 533 patients" published in paper copy in Gut in January 2021, and online, here: https://gut.bmj.com/content/70/1/40

Comments

Login or signup comment.